Literature DB >> 22804356

Upstaging of early colorectal cancers following improved lymph node yield after methylene blue injection.

Rikke Karlin Jepsen1, Peter Ingeholm, Eva Løbner Lund.   

Abstract

AIMS: To evaluate whether the use of intra-arterial methylene blue injection improves lymph node yield, and to determine whether a higher lymph node count results in upstaging in colorectal cancer. METHOD AND
RESULTS: We performed a retrospective study of colorectal cancer specimens (n = 234) 1 year after implementation of the method. All colorectal cancer specimens from the previous year served as our control group. Data concerning tumour characteristics, lymph node count, number of positive lymph nodes and success of methylene injection had been prospectively collected in accordance with the department's ongoing registration. The method was easy to implement and perform with a high rate of success (86%). The number of identified lymph nodes was highly significantly improved in the study group (P < 0.0001). In resections with pT1/T2 tumours, we demonstrated a significant increase in the number of resection specimens containing positive lymph nodes, with an increase in pN1 resections from 9.4% in the control group to 26.7% in the study group (P = 0.04).
CONCLUSIONS: THE methylene blue technique significantly improves lymph node identification in colorectal cancer specimens, and the improved lymph node identification leads to upstaging of International Union Against Cancer (UICC) pT1/pT2 cancers.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22804356     DOI: 10.1111/j.1365-2559.2012.04287.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review.

Authors:  P Quirke; N P West; I D Nagtegaal
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

2.  What Is the Minimum Number of Examined Lymph Nodes After Neoadjuvant Therapy in Rectal Cancer?

Authors:  Peng Gao; Yongxi Song; Yuchong Yang; Shan Zhao; Yu Sun; Jingxu Sun; Xiaowan Chen; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-02-21       Impact factor: 3.452

3.  Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.

Authors:  Patrick Mayr; Georg Aumann; Tina Schaller; Gerhard Schenkirsch; Matthias Anthuber; Bruno Märkl
Journal:  Langenbecks Arch Surg       Date:  2016-02-16       Impact factor: 3.445

4.  Endoscopic ultrasonography and computed tomography scanning for preoperative staging of colonic cancer.

Authors:  M L Malmstrøm; I Gögenur; L B Riis; H Hassan; T W Klausen; T Perner; A Săftoiu; P Vilmann
Journal:  Int J Colorectal Dis       Date:  2017-04-21       Impact factor: 2.571

Review 5.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 6.  [Lymph node staging in gastrointestinal cancer. Combination of methylene blue-assisted lymph node dissection and ex vivo sentinel lymph node mapping].

Authors:  B Märkl; H Arnholdt
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.